10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
MERCK & CO., INC. | |||
Ticker: MRK Fiscal Year: 2019 | |||
Consolidated Statement of Cash Flows | |||
Period Ending Dec 31, 2019 10-K (Filed: Feb 26, 2020) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
| Cash Flows from Operating Activities | |||
| Net income | $ 9,777 | 6,193 | 2,418 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | 3,652 | 4,519 | 4,676 |
| Intangible asset impairment charges | 1,040 | 296 | 646 |
| Charge for the acquisition of Peloton Therapeutics, Inc. | 993 | 0 | 0 |
| Charge for future payments related to collaboration license options | 0 | 650 | 500 |
| Provisional charge for one-time transition tax related to the enactment of U.S. tax legislation | 0 | 0 | 5,347 |
| Deferred income taxes | (556) | (509) | (2,621) |
| Share-based compensation | 417 | 348 | 312 |
| Other | 184 | 978 | 190 |
| Net changes in assets and liabilities: | |||
| Accounts receivable | 294 | (418) | 297 |
| Inventories | (508) | (911) | (145) |
| Trade accounts payable | 399 | 230 | 254 |
| Accrued and other current liabilities | 376 | (341) | (922) |
| Income taxes payable | (2,359) | 827 | (3,291) |
| Noncurrent liabilities | (237) | (266) | (123) |
| Other | (32) | (674) | (1,087) |
| Net Cash Provided by Operating Activities | 13,440 | 10,922 | 6,451 |
| Cash Flows from Investing Activities | |||
| Capital expenditures | (3,473) | (2,615) | (1,888) |
| Purchases of securities and other investments | (3,202) | (7,994) | (10,739) |
| Proceeds from sales of securities and other investments | 8,622 | 15,252 | 15,664 |
| Acquisition of Antelliq Corporation, net of cash acquired | (3,620) | 0 | 0 |
| Acquisition of Peloton Therapeutics, Inc., net of cash acquired | (1,040) | 0 | 0 |
| Other acquisitions, net of cash acquired | (294) | (431) | (396) |
| Other | 378 | 102 | 38 |
| Net Cash (Used in) Provided by Investing Activities | (2,629) | 4,314 | 2,679 |
| Cash Flows from Financing Activities | |||
| Net change in short-term borrowings | (3,710) | 5,124 | (26) |
| Payments on debt | 0 | (4,287) | (1,103) |
| Proceeds from issuance of debt | 4,958 | 0 | 0 |
| Purchases of treasury stock | (4,780) | (9,091) | (4,014) |
| Dividends paid to stockholders | (5,695) | (5,172) | (5,167) |
| Proceeds from exercise of stock options | 361 | 591 | 499 |
| Other | 5 | (325) | (195) |
| Net Cash Used in Financing Activities | (8,861) | (13,160) | (10,006) |
| Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash | 17 | (205) | 457 |
| Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash | 1,967 | 1,871 | (419) |
| Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes $2 million of restricted cash at January 1, 2019 included in Other Assets) | 7,967 | 6,096 | |
| Cash, Cash Equivalents and Restricted Cash at End of Year (includes $258 million of restricted cash at December 31, 2019 included in Other Assets - see Note 6) | 9,934 | 7,967 | 6,096 |
| External Links | |
| MERCK & CO., INC. (MRK) Fiscal Year 2019 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |